These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8892036)

  • 21. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine.
    Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T
    J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
    Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
    Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model with two types of CTL regulation and experiments on CTL dynamics.
    Sergeev RA; Batorsky RE; Rouzine IM
    J Theor Biol; 2010 Apr; 263(3):369-84. PubMed ID: 19913558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of CD8+ cell-produced anti-viral factors in protective immunity in HIV-2-exposed but seronegative macaques resistant to intrarectal SIVsm challenge.
    Ahmed RK; Nilsson C; Biberfeld G; Thorstensson R
    Scand J Immunol; 2001 Mar; 53(3):245-53. PubMed ID: 11251881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.
    Kaul R; Dong T; Plummer FA; Kimani J; Rostron T; Kiama P; Njagi E; Irungu E; Farah B; Oyugi J; Chakraborty R; MacDonald KS; Bwayo JJ; McMichael A; Rowland-Jones SL
    J Clin Invest; 2001 May; 107(10):1303-10. PubMed ID: 11375420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preinfection human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes failed to prevent HIV type 1 infection from strains genetically unrelated to viruses in long-term exposed partners.
    Liu Y; Woodward A; Zhu H; Andrus T; McNevin J; Lee J; Mullins JI; Corey L; McElrath MJ; Zhu T
    J Virol; 2009 Oct; 83(20):10821-9. PubMed ID: 19706711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers.
    Kaul R; Rowland-Jones SL; Kimani J; Fowke K; Dong T; Kiama P; Rutherford J; Njagi E; Mwangi F; Rostron T; Onyango J; Oyugi J; MacDonald KS; Bwayo JJ; Plummer FA
    Immunol Lett; 2001 Nov; 79(1-2):3-13. PubMed ID: 11595284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
    Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
    Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
    J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-infected macrophages as efficient stimulator cells for detection of cytotoxic T cell responses to HIV in seronegative and seropositive vaccine recipients.
    McElrath MJ; Hoffman M; Kluckling S; Corey L; Greenberg PD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):541-9. PubMed ID: 7917516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques.
    Gallimore A; Cranage M; Cook N; Almond N; Bootman J; Rud E; Silvera P; Dennis M; Corcoran T; Stott J
    Nat Med; 1995 Nov; 1(11):1167-73. PubMed ID: 7584989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.
    Rowland-Jones SL; Nixon DF; Aldhous MC; Gotch F; Ariyoshi K; Hallam N; Kroll JS; Froebel K; McMichael A
    Lancet; 1993 Apr; 341(8849):860-1. PubMed ID: 8096564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
    Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new look at HIV transmission from seropositive mothers to their infants: the facts beyond serology.
    Jehuda-Cohen T
    Isr J Med Sci; 1994; 30(5-6):364-8. PubMed ID: 8034484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
    Estaquier J; Idziorek T; de Bels F; Barré-Sinoussi F; Hurtrel B; Aubertin AM; Venet A; Mehtali M; Muchmore E; Michel P; Mouton Y; Girard M; Ameisen JC
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9431-5. PubMed ID: 7937784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
    Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
    J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes.
    Geretti AM; Osterhaus AD
    Immunol Rev; 2001 Oct; 183():109-14. PubMed ID: 11782251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.